Company News

Share this article:

Bristol-Myers Squibb will acquire Medarex, a biopharma focused on antibody-based therapeutics for the treatment life-threatening or debilitating diseases, for $2.4 billion. The deal includes full ownership of ipilimumab, a melanoma treatment in phase 3, which BMS called a potentially “important contributor to…future growth,” in a statement.

Digital detailer Physicians Interactive has acquired Skyscape, a mobile health information provider. Skyscape's user base exceeds one million medical practitioners, according to a release. Terms of the deal were not disclosed.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.